To quote Jennifer Lopez ,“C’mon people, let’s get loud!” Hang up your lab coat, leave your pad folios and ipads behind, and dust off your protest sign, it’s time to make some noise for medical research!
you are not alone! Comparative effectiveness research (CER) is a tool that can have a significant effect on those receiving health care, particularly older Americans. When used correctly, CER can help ensure that seniors facing illnesses receive the best care for their condition. However, many open questions remain around this critical issue.
Petitions are now in vogue and far be it for us to miss the bandwagon, especially when the White House website is hosting petitions on everything from letting Texas secede to deporting CNN's Piers Morgan. And now, a particularly meaningful petition to those of us at the Alliance for Aging Research has recently cropped up. This Alzheimer's petition holds the White House’s and Congress’ feet to the fire on the goals of the first national Alzheimer’s plan—and I am asking you to sign it.
This week the Alliance for Aging Research and the U.S. Administration on Aging (AoA) released a new white paper titled Translating Innovation to Impact: Evidence-based interventions to support people with Alzheimer's disease and their caregivers at home and in their communities. The white paper was written by Katie Maslow, MSW, Scholar-in-Residence at the Institute of Medicine, but the findings in the paper are the result of a review of the state of the art of non-pharmacological treatments and care practices that began with a public-private meeting on June 28, 2012.
The Alliance for Aging Research was pleased to be a co-sponsor of the National Pharmaceutical Council’s Myth of the Average Patient Conference in Washington, D.C. I had the opportunity to attend the event and share my thoughts on why the topic of heterogeneity among patients is important to consider when conducting comparative effectiveness research.
Full report can be found here:The_Medicare_Advantage_Experience (PDF Format)
Millions of people live with glaucoma without knowing that they have the disease. There are many types of glaucoma, with most associated with elevated eye pressure that can damage the optic nerve and cause vision loss. That vision loss can usually be prevented with early detection and proper treatment/management. Unfortunately, the disease can progress silently without any noticeable symptoms, and for someone who doesn’t know they have it, they may end up with vision loss before they are ever diagnosed. And once the damage is done, it’s irreversible.
David Stipp is a prominent science writer who has focused on medicine, science, and aging for decades for publications like The Wall Street Journal, Fortune, Slate, Science, and more. The Alliance for Aging Research was very fortunate to have Stipp author a whitepaper--The Transformative Promise of Aging Science--to help launch our Healthspan Campaign earlier this year.